Abstract
Several distinct clinical syndromes may be produced by the secretion of excess adrenal cortical hormones. Excessive production of the principal mineralocorticoid, aldosterone, results in clinical and chemical signs of aldosteronism, and adrenal virilism may result from excessive production of adrenal androgens. Neuropsychiatric changes are most prominently associated with an excess of the principal glucocorticoid, cortisol.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Addison T: On the Constitutional and Local Effects of Disease of the Supra-renal Capsules. London, S Highby, 1855.
Agras S, Oliveau DC: Primary hyperparathyroidism and psychosis. Can Med Assoc J 91: 1366–1367, 1964.
Anderson J: Psychiatric aspects of primary hyperparathyroidism. Proc R Soc Med 61: 1123–1124, 1968.
Anthony D, Dippe S, Hofeldt FD, et al: Personality disorder and reactive hypoglycemia. Diabetes 22: 664–675, 1973.
Asher R: Myxedematous madness. Br Med J 2: 555–562, 1949.
Axelrod J: Neural and endocrine control of catecholamine biosynthesis. Proc Fourth Int Congr Endocrinol. Amsterdam, Excerpta Medica, 1973.
Barnes VH, Greenberg AH, Owings J, et al: The effect of chlorodiazepoxide (Librium) on thyroid function and thyrotoxicosis. Johns Hopkins Med J 131: 298–300, 1972.
Baron JM: Chlorodiazepoxide (Librium) and thyroid function tests. Br Med J 1:699, 1967..
Beck HG: The hallucinations of myxedema. Med Times 54: 201–203, 1926.
Beidelman B: Treatment of chronic hypoparathyroidism with probenecid. Metabolism 7: 690–698, 1958.
Berardinelli G: Pseudo-hypoparathyroidism with decreased glucose tolerance and diabetes insipidus. Acta Endocrinol 7: 16–19, 1951.
Berger H: Hypoglycemia: A perspective. Postgrad Med 57: 81–85, 1975.
Bergeron R, Murphy R, Warren K: Acute pancreatitis, acute hyperparathyroidism and low magnesium syndrome: A case report. Lahey Clinic Bull 12: 186–190, 1961.
Bernstein IC: A case of hypothyroidism presenting as a psychiatric illness. Psychosomatics 6: 215–216, 1965.
Berry M: Studies of the unknown factors in duodenal ulcer: Hypoglycemia as a possible etiologic factor. Am J Gastroenterol 27: 31–34, 1957.
Bessher PD, Gardiner AQ, Hedley AJ, et al: Psychosis after alteration of thyroid status. Psychol Med 1: 260–262, 1971.
Bleuler M: Endocrinological medicine and psychiatry. Henry Ford Hosp Med 115: 309–317, 1967.
Bluestone H: Hyperthyroidism masquerading as functional psychosis. Am Pract Digest Treat 8: 557–558, 1957.
Blumberg AG, Klein DF: Chlorpromazine–procyclidine and imipramine: Affects on thyroid function in psychiatric patients. Clin Pharmacol Ther 10: 2350–2355, 1969.
Borman MD, Schmallenberg HC: Suicide following cortisone treatment. JAMA 146: 337–338, 1951.
The Boston Collaborative Drug Surveillance Program: Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13: 694–698, 1972.
Bovil D: A case of functional hypoglycemia-a medico-legal problem. Br JPsychiatry 123: 353–358, 1973.
Boyd IH, Cleveland SE: Psychiatric symptoms masking an insulinoma. Dis New Syst 28: 457–458, 1967.
Boyd JD, Malgram JE, Stearns G: Clinical hyperparathyroidism. JAMA 93: 684–688, 1929.
Brewer C: Psychosis due to acute hypothyroidism during the administration of carbimazole. Br J Psychiatry 115: 1181–1183, 1969.
Bronsky D: Idiopathic hypoparathyroidism and pseudohypoparathyroidism. Medicine 37: 317–352, 1958.
Browning TB, Atkins RW, Weiner H: Cerebral metabolic disturbances in hypothyroidism. Arch Intern Med 93: 938–950, 1954.
Brownlie BE, Chambers ST, Sadler WA, et al: Lithium–associated thyroid disease A report of 14 cases of hypothyroidism and 4 cases of thyrotoxicosis. Aust NZ J Med 6: 223–229, 1976.
Burch EA, Messervy PW: Psychiatric symptoms in medical illness: Hyperthyroidism revisited. Psychosomatics 19: 71–75, 1978.
Burman KD, Cunningham EJ, Klachko DM, et al: Factitious hypoglycemia. Am J Med Sci 263: 23–30, 1973.
Burns TW, Bregand R, van Deenen HJ, et al: Observations on blood glucose concentrations of human subjects during continuous sampling. Diabetes 14: 186–193, 1965.
Bursten B: Psychoses associated with thyrotoxicosis. Arch Gen Psychiatry 4: 267–273, 1961.
Cahil GF, Soeldner JS: A non–editorial on nonhypoglycemia. N Eng J Med 291: 905–906, 1974.
Camp JD: Symmetrical calcification of cerebral basal ganglia. Radiology 49:568–577, 1947. Carmen JC, Wyatt RJ: Use of calcitonin in psychotic agitation or mania. Arch Gen Psychiatry 36: 72–75, 1979.
Christensson TAT: Lithium, hypercalcaemia, and hyperparathyroidism. Lancet 2: 144, 1976.
Christiansen C, Baastrup PC, Transbol I: Lithium, hypercalcaemia, hypermagnesaemia, and hyperparathyroidism. Lancet 2: 969, 1976.
Clark F, Ormston BJ: Diazepam and tests of thyroid function. Br Med J 1: 585–586, 1971.
Clark LD, Bauer W, Cobb S: Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N Eng J Med 256: 205–216, 1952.
Clark LD, Quarton GC, Cobb S, et al: Further observations on mental disturbances associated with cortisone and ACTH therapy. N Eng J Med 249: 178–183, 1953.
Cleghorn RA: Adrenocortical insufficiency: Psychological and neurologic observations. Can Med Assoc J 65: 449–454, 1951.
Clower CG, Young AJ, Kepas D: Psychotic states resulting from disorders of thyroid function. Johns Hopkins Med J 124: 305–310, 1969.
Conn JW: Functional hyperinsulinism. A common and well defined clinical entity amendable to medical management. J. Michigan State Med Soc 46: 451–457, 1947.
Cooper AF, Schapiru K: Case report: Depression, catatonic stupors and EEG changes in hyperparathyroidism. Psychol Med 3: 509–515, 1973.
Cope O: Hyperparathyroidism. Am J Surg 99: 394–398, 1967.
Cronin AJ: The Citadel. V Gollancz Ltd, London, 1937.
Cushing H: Basophil adenomas of the pituitary body and their clinical manifestations. Bull John Hopkins Hosp 50: 137–195, 1932.
Davis PJ: Factors affecting the determination of the serum protein–bound iodine. Am J Med 40: 918–921, 1966.
Denko J, Kaelbling T: The psychiatric aspects of hypoparathyroidism. Acta Psychiatr Scand 38: 7–70, 1962.
DeVos JA: Deafness in hypothyroidism. J Laryngol Otol 77: 390–392, 1963.
Dysken MW, Halaris AE: Post–ECT asterixis associated with primary hyperparathyroidism. Am J Psychiatry 135: 1237–1238, 1978.
Earle BV: Thyroid hormone and tricyclic anti–depressants in resistant depressions. Am J Psychiatry 126: 1667–1669, 1970.
Easson WM: Myxedema with psychosis. Arch Gen Psychiatry 14:277–283, 1966
Ebaugh FG, Drake FR: Neuropsychiatric-like symptomatology of Addison’s disease: A review. Am J Med Sci 234: 106–113, 1957.
Eitinger L: Hyperparathyroidism with mental changes. Nord Med 14: 1581–1585, 1942.
Engle GL, Margolin SG: Neuropsychiatric disturbances in internal disease. Arch Intern Med 70: 236–259, 1941.
Evensen OK: Alimentary hypoglycemia after stomach operations and influence of gastric emptying on glucose tolerance curve. Acta Med Scand 126 (suppl): 1–4, 1942.
Fabrykant M: The problem of functional hyperinsulinism or functional hypoglycemia attributed to nervous causes: I. Laboratory and clinical correlations. Metabolism 4: 469–479, 1955a.
Fabrykant M: The problem of functional hyperinsulinism or functional hypoglycemia attributed to nervous causes: II. Dietary and neurogenic factors. Metabolism 4: 480–490, 1955b.
Fajans SS: Hyperinsulinism, hypoglycemia, and glucagon secretion, in Thorn G, Adams RD, Braunwald E, et al (eds): Harrison’s Principles of Internal Medicine, ed 8. New York, McGraw Hill, 1977, pp 586–595.
Falk WE, Mahnke MW, Poskanzer DC: Lithium prophylaxis of corticotropin–induced psychosis. JAMA 241: 1011–1012, 1979.
Fawcett JA, Bunney WE: Pituitary adrenal function and depression. Arch Gen Psychiatry 16: 517–535, 1967.
Federal Drug Administration: Suspected adverse reaction to drugs. #690101–083–00201. Fonseca OA, Calverley JR: Neurologic manifestations of hypoparathyroidism. Arch Intern Med 120: 202–206, 1967.
Ford CV, Bray GA, Swerdloff RS: A psychiatric study of patients referred with a diagnosis of hypoglycemia. Am J Psychiatry 133: 290–294, 1976.
Fourman P, Davis RH, Jones KH, et al: Parathyroid insufficiency after thyroidectomy: A review of 46 patients with a study of the effects of hypocalcemia on the electroencephalogram. Br J Surg 50: 608–619, 1963.
Fourman P, Rawnsley K, Davis RH, et al: Effect of calcium on mental symptoms in partial parathyroid insufficiency. Lancet 2: 914–915, 1967.
Freyberg RH, Traeger CH, Patterson M, et al: Problems of prolonged cortisone treatment for rheumatoid arthritis: Further investigations. JAMA 147: 1538–1543, 1951.
Garfinkel PE, Ezrin C, Stancer HG: Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 2: 331–332, 1973.
Gatewood JW, Organ CH, Meade BT: Mental changes associated with hyperparathyroidism. Am J Psychiatry 132: 129–132, 1975.
Gibson JG: Emotions and the thyroid gland: A critical appraisal. J. Psychosom Res 6: 93–116, 1962.
Glaser GH: Psychotic reactions induced by corticotropin (ACTH) and cortisone. Psychosom Med 15: 280–291, 1953.
Goldman R: The effect of ACTH on one case of periarteritis nodosa, in Mote JR (ed): Proceedings of the First Clinical ACTH Conference. Philadelphia, Blakiston, 1950, p 437.
Goolker P, Schein J: Psychic effects of ACTH and cortisone. Psychosom Med 15: 589–613, 1953.
Greene JA, Swanson LW: Psychosis in hypoparathyroidism: Report of five cases. Ann Intern Med 14: 1233–1236, 1941.
Gregory R, Andersch M: The filterable calcium of blood serum. Am J Med Sci 110: 263–271, 1936.
Groschel W, Kluge H, Zhalten W, et al: Vergleichende Untersuchungen zum elecktrolytye Rhalten im Serum bei liprophylzne zyklothymer Psychosen. Pharmakopsych-Euro-Psychopharmakol 7: 300–306, 1974.
Gull WW: On a cretinoid state supervening in adult life in women. Trans Clin Soc London 7: 180–185, 1873.
Gupta VP, Ehrlich GE: Organic brain syndrome in rheumatoid arthritis following corticosteroid withdrawal. Arthritis Rheum 19: 1333–1338, 1976.
Hafken L, Leichter S, Reich T: Organic brain dysfunction as a possible consequence of postgastrectomy hypoglycemia. Am J Psychiatry 132: 1321–1324, 1975.
Hall RW, Popkin MK, Kirkpatrick B: Tricyclic exacerbation of steroid psychoses. J Nery Ment Dis 166: 738–742, 1978.
Hamadah K, Teggin AF: Haloperidol, thyrotoxicosis and neurotoxicity. Lancet 2: 1019–1020, 1974.
Hansten PD: Drug Interactions. Philadelphia, Lea & Febiger, 1976, p 271.
Harris S: Hyperinsulinism and dysinsulinism. JAMA 83: 729–733, 1924.
Hermann HT, Quarton GC: Psychological changes and psychogenesis in thyroid hormone disorders. J Clin Endocrinol 25: 327–338, 1965.
Herridge CF, Abey-Wickrama I: Acute iatrogenic hypothyroid psychosis. Br Med J 3: 154, 1969.
Hoefer PFA, Glaser GH: Effects of pituitary adrenocorticotrophic hormone (ACTH) therapy. JAMA 143: 620–622, 1950.
Hofeldt FD: Reactive hypoglycemia. Metab Clin Exp 24: 1193–1208, 1975.
Hoffman WC, Lewis RA, Thorn GW: Electroencephalogram in Addison’s disease. John HopkinsHosp Bull 70: 335–361, 1942.
Hoffman WH, Chodoroff G, Piggott LR: Haloperidol and thyroid storm. Am J Psychiatry 135: 484–486, 1978.
Hollister LE: Clinical Pharmacology of Psychotherapeutic Drugs. New York, Churchill Livingstone, 1978.
Hullen RP: Magnesium, in Johnson FN (ed): Lithium Research and Therapy. New York, Academic Press, 1975, pp 369–372.
Hurxthal LM, O’Sullivan JB: Cushing’s syndrome: Clinical differential diagnosis and complications. Ann Intern Med 51: 1–16, 1959.
Ingbar SH, Waeber KA: Diseases of the thyroid, in Thorn G. Adams RD, Braunwald E, et al (eds): Harrison’s Principles of Internal Medicine, ed 8. New York, McGraw–Hill, 1977, pp 501–508.
Jain VK: A psychiatric study of hypothyroidism. Psychiatr Clin 5: 121–130, 1972.
Jefferson JW, Greist JH: Primer of Lithium Therapy. Baltimore, Williams & Wilkins, 1977.
Josefson AM, MacKeanzie TB: Appearance of manic psychosis following rapid normalization of thyroid status. Am J Psychiatry 136: 846–847, 1979.
Kates AG, Beall N, Bagor GF, et al: Sleep studies in asthmatic adults: Relationship of attacks to sleep stage and time of night. J Allergy 41: 164–173, 1968.
Karpati G, Frame B: Neuropsychiatric disorders of primary hyperparathyroidism. Arch Neural 10: 387–397, 1964.
Kind H: Psychische Stroungen bei Hyperparathyreoidismus. Arch Psychiatr Nervenkr 200: 1–11, 1959.
Kleinschmidt HJ, Waxenberg SE, Cuker R: Psychophysiology and psychiatric management of thyrotoxicosis: A two-year follow-up study. J Mt Sinai Hosp 23: 131–153, 1956.
Krieger DT, Gewirtz GP: Recovery of hypothalamic-pituitary-adrenal function, growth hormone responsiveness and sleep EEG pattern in a patient following removal of an adrenocortical adenoma. J Clin Endocrinol 38: 1075–1078, 1974.
Lackey FH: Non-activated (apathetic) type of hyperthyroidism. N Eng J Med 294: 747–748, 1931.
Lake CR, Fann WE: Possible potentiation of haloperidol neurotoxicity in acute hyperthyroidism. Br J Psychiatry 123: 523–525, 1973.
Leggett J, Favazza AR: Hypoglycemia: An overview. J Clin Psychiatry 39:51–57, 1978. Levine R: Hypoglycemia. JAMA 230: 462–463, 1974.
Lidz T: Emotional factors in the etiology of hyperthyroidism. Psychosom Med 11: 2–8, 1949.
Lidz T, Carter JD, Lewis BI, et al: Effects of ACTH and cortisone on mood and mentation. Psychosom Med 14: 363–377, 1952.
Lindstedt G, Nilsson L, Walinder J, et al: On the prevalence, diagnosis, and management of lithium–induced hypothyroidism in psychiatric patients. Br J Psychiatry 130: 452–458, 1977.
Logothetis J: Psychotic behavior as the initial indicator of adult myxedema. J. Nery Ment Dis 136: 561–568, 1963.
McConnell RJ, Menendez CE, Smith FR, et al: Defects of taste and smell in patients with hypothyroidism. Am J Med 59: 354–364, 1975.
MacCrimmon DJ, Wallace JE, Goldberg W, et al: Emotional disturbance and cognitive deficits in hyperthyroidism. Psychosom Med 41: 331–340, 1979.
Malden M: Hypothermic coma in myxedema. Br Med J 2: 764–765, 1955.
Mazzaferri EL, Skillman EG: Diazepam (Valium) and thyroid function: A double blind, placebo controlled study in normal volunteers showing no drug effect. Am J Med Sci 248: 129–132, 1964.
Merimee TJ: Spontaneous hypoglycemia in man. Adv Intern Med 22: 301–317, 1977.
Michael RR, Gibbons JL: Interrelationships between the endocrine system and neuropsychiatry, in Pfeiffer CC, Smythies JR (eds): International Review of Neurobiology. New York, Academic Press, 1963, vol 5, pp 243–302.
Mikkelsen EJ, Reider AA: Post–parathyroidectomy psychosis: Clinical and research implications. J Clin Psychiatry 40: 352–357, 1979.
Mills IH: Clinical Aspects of Adrenal Function. Philadelphia, FA Davis, 1964.
Noble P: Depressive illness and hyperparathyroidism. Proc R Soc Med 67: 1066–1067, 1974.
Olivarus B. de F., Roder E: Reversible psychosis and dementia in myxoedema. Acta Psychiatr Scand 46: 1–13, 1970.
Park S: Enhancement of anti-psychotic effect of chlorpromazine with L-triiodothyronine, in Prange AJ (ed): The Thyroid Axis, Drugs and Behavior. New York, Raven Press, 1974, pp 75–86.
Permutt MA; Postprandial hypoglycemia. Diabetes 25: 719–733, 1976.
Petersen P: Psychiatric disorders and primary hyperparathyroidism. JClin Endocrinol 28: 1491–1495, 1968.
Pitts FN, Guze SB: Psychiatric disorders and myxedema. Am J Psychiatry 118:142–147, 1961. Post JT: Hypothyroid deafness. A clinical study of sensorineural deafness associated with hypothyroidism. Laryngoscope 74: 221–224, 1964.
Potts JT, Roberts B: Significance of magnesium deficiency and its relation to parathyroid disease. Am J Med Sci 235: 206–219, 1958.
Prange AJ, Jr, Wilson IC, Knox A, et al: Enhancement of imipramine by thyroid stimulating hormone: Clinical and theoretical implications. Am J Psychiatry 127: 191–199, 1970.
Prange AJ, Jr, Wilson IC, Breese GR, et al: Hormonal alteration of imipramine response: A review, in Sacher EJ (ed): Hormones, Behavior, and Psychopathology. New York, Raven Press, 1976, pp 41–67.
Quarton GC, Clark LD, Cobb S, et al: Mental disturbances associated with ACTH and cortisone: A review of explanatory hypotheses. Medicine 34: 13–50, 1955.
Reinfrank RF: Primary hyperparathyroidism with depression. Arch Intern Med (Chicago) 108: 606–610, 1961.
Reus VI, Gold T, Post R: Lithium–induced thyrotoxicosis. Am J Psychiatry 136: 724–725, 1979.
Robbins LR, Vinson DB: Objective psychological assessment of the thyrotoxic patient and the response to treatment: Preliminary report. J Clin Endocrinol 20: 120–129, 1960.
Rome HP, Braceland FJ: The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry 108: 641–651, 1952.
Rosser R: Thyrotoxoicosis and lithium. Br J Psychiatry 128: 61–66, 1976.
Sacher EJ: Psychiatric disturbances associated with endocrine disorders, in Arieti S (ed): The American Handbook of Psychiatry, ed 2. New York, Basic Books, 1975, vol 4, pp 300–303.
Sasenbach W, Madison L, Eisenberg S, et al: The cerebral circulation and metabolism in hyperthyroidism and myxedema. J Clin Invest 33: 1444–1450, 1954.
Scheinberg, Stead EA, Brannon ES, et al: Correlative observations on cerebral metabolism and cardiac output in myxedema. J Clin Invest 29: 1139–1146, 1950.
Schon M, Sutherland AM, Rawson RW: Hormones and neurosis—the psychological effects of thyroid deficiency. Proc Third World Cong Psychiatr 2: 835–839, 1961.
Schussler GC: Diazepam competes with thyroxine binding sites. J Pharmacol Exp Ther 178: 204–207, 1971.
Selye H, Szabo S: Protection against haloperidol by catatoxic steroids. Psychopharmacol 24: 430–434, 1972.
Siegal FP: Lithium for steroid–induced psychosis. N Eng J Med 299: 155–156, 1978.
Singer FR, Bethune JE, Massry SG: Hypercalcemia and hypocalcemia. Clin Nephrol 7: 154–162, 1977.
Smith CK, Barrish J, Correa J, et al: Psychiatric disturbance in endocrinologic disease. Psychosom Med 34: 69–86, 1972.
Snowdon JA, MacFie AC, Pearce JB: Hypocalcaemic myopathy with paranoid psychosis. J Neuro Neurosurg Psychiat 39: 448–452, 1976.
Sorkin SZ: Addison’s disease. Medicine 28: 371–425, 1949.
Sparagana M, Rubnitz ME: Hypoglycemia presenting with neuropsychiatric symptoms. Postgrad Med 51: 192–196, 1972.
Spillane JD: Nervous and mental disorders in Cushing’s syndrome. Brain 74: 72–94, 1951.
Starr AM: Personality changes in Cushing’s syndrome. J Clin Endocrinol 12: 502–505, 1952.
Thomas FB, Mazzaferri EL, Skillman TG: Apathetic thyrotoxicosis: A distinctive clinical and laboratory entity. Ann Intern Med 72: 679–685, 1970.
Tonks CM: Mental illnesses in hypothyroid patients. Br J Psychiatry 110: 706–710, 1964.
Treadway CR, Prange A), Jr, Doehne EF, et al: Myxedema psychosis: Clinical and biochemical changes during recovery. J Psychiatr Res 5: 289–296, 1967.
Trethowan WH, Cobb S: Neuropsychiatric aspects of Cushing’s syndrome. Arch Neurol Psychiatry 67: 283–309, 1952.
Uitert RV, Russakoff LM: Hyperthyroid chorea mimicking psychiatric disease. Am J Psychiatry 136: 1208–1210, 1979.
Von Jauregg JW: Myxedema and cretinism, in Aschaffenburg G (ed): Handbuch der Psychiatrie. Leipzig and Vienna, F Deutiche, 1912, vol 2, p 12.
Voth HM, Holzman PS, Kats JB, et al: Thyroid hot spots: Their relationship to life stress. Psychosom Med 32: 561–580, 1970.
Ward DJ, Rasta11 ML: Prognosis in “myxedematous madness.” Br JPsychiatry 113: 149–151, 1967.
Weiner MF: Haloperidol, hyperthyroidism, and sudden death. Am J Psychiatry 136: 717–718, 1979.
Weinberg AD, Katzell TD: Thyroid and adrenal function among psychiatric patients. Lancet 1: 1104–1105, 1977.
Wheatley D: Potentiation of amitriptyline by thyroid hormone. Arch Gen Psychiatry 26: 229–231, 1972.
Whelton MJ, Samols E, Williams HS, et al: Factitious hypoglycemia in the diabetic, metabolic studies and diagnosis with radioisotopes. Metab Clin Exp 17: 923–927, 1968.
Whipple AO: Hyperinsulinism in relation to pancreatic tumor. Surgery 16: 289–293, 1944.
Whybrow PC, Prange AJ, Treadway CR: Mental changes accompanying thyroid gland dysfunction. Arch Gen Psychiatry 20: 48–63, 1969.
Wilder RM: Clinical Diabetes Mellitus and Hyperinsulinism. Philadelphia, Saunders, 1941.
Wilder RM, Allan FN, Power MH, et al: Carcinoma and islands of pancreas: Hyperinsulinism and hypoglycemia. JAMA 89: 348–350, 1927.
Williams GH, Dluhy RG, Thorn GW, et al: Diseases of the adrenal cortex, in Thorn G. Adams RD, Braunwald E, et al (eds): Harrison’s Principles of Internal Medicine, ed 8. New York, McGraw Hill, 1977, pp 520–556.
Williams RH: The pancreas, in Williams RH (ed): Textbook of Endocrinology. Philadelphia, Saunders, 1968, pp 613–802.
Wilson I, Prange AJ, McClane TK, et al: Thyroid–hormone enhancement of imipramine in nonretarded depressions. N Eng J Med 282: 1063–1067, 1970.
Wilson WP, Johnson JE, Feist FW: Thyroid hormone and brain function: II. Changes in photically elicited EEG responses following the administration of triiodothyronine to normal subjects. Electroencephalogr Clin Neurophysiol 16: 329–331, 1964.
Woodbury DM: Relation between the adrenal cortex and the central nervous system. PharmacolRev 10: 275–357, 1958.
Yager J, Young RT: Non–hypoglycemia in an epidemic condition. N Eng J Med 291: 907–908, 1974.
Yosselson S, Kaplan A: Neurotoxic reaction to haloperidol in a thyrotoxic patient. N Engl J Med 293: 201, 1975.
Zieve L, Jones DG, Aziz MA: Functional hypoglycemia and peptic ulcer. Postgrad Med 40: 159–170, 1966.
Zivin I: The neurological and psychiatric aspects of hypoglycemia. Dis New Syst 31: 604–607, 1970.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Publishing Corporation
About this chapter
Cite this chapter
Jefferson, J.W., Marshall, J.R. (1981). Endocrine Disorders. In: Neuropsychiatric Features of Medical Disorders. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3920-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3920-5_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3922-9
Online ISBN: 978-1-4684-3920-5
eBook Packages: Springer Book Archive